CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

The Latest News and Updates in Chronic Lymphocytic Leukemia

June 8th 2020, 7:12pm

Article

Here is a roundup of the latest news and updates for patients with Chronic Lymphocytic Leukemia from CURE.

Long-Term Data Support Use of Venclexta-Gazyva in Patients With Previously Untreated Chronic Lymphocytic Leukemia

June 5th 2020, 1:21am

Article

“The superior efficacy of venetoclax-obinutuzumab has been observed and maintained in the current follow up,” Dr. Othman Al-Sawaf, of University Hospital of Cologne in Germany, said during a pre-recording presentation at the 2020 ASCO Virtual Scientific Program.

Calquence Shows Favorable Long-Term Outcomes in Treatment-Naive Chronic Lymphocytic Leukemia

June 4th 2020, 7:09pm

Article

“Collectively, these results support acalabrutinib (Calquence) use in upfront CLL,” said Dr. John C. Byrd. “This is compounded and supported by two additional phase III studies that have been completed with this agent.”

Novel Combination Therapy Shows Exciting Results in Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma

June 3rd 2020, 10:00pm

Article

Results from an early-phase trial showed that cirmtuzumab plus Imbruvica is safe and efficacious in treating patients with relapsed/refractory MCL and CLL.

Infection Risks, Impact of COVID-19 in Stem Cell Transplants for Blood Cancers

May 12th 2020, 1:17am

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Dr. Farukh Awan addressed concerns about the possibility of developing COVID-19 or any infection after a stem cell transplant to treat a blood cancer.

Blood Cancer Therapies May Play a Role in Treating COVID-19

May 7th 2020, 7:00pm

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Drs. Zainab Shahid, Farukh Awan and Ian Flinn addressed clinical trials that are underway to assess therapeutic approaches to COVID-19, including what role BTK inhibitors might play in treating the virus.

One Cancer Organization's Observations on the Impact of COVID-19 on the Blood Cancer Community

May 6th 2020, 10:00pm

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Lee Greenberger addresses steps that the Leukemia and Lymphoma Society have taken to help patients with blood cancer during the COVID-19 pandemic.

How Patients With Blood Cancers Can Boost Immune Systems to Fight Infections Like COVID-19

May 6th 2020, 7:02pm

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients,” Drs. Ian Flinn and Farrukh Awan addressed what patients with blood cancers could do to help boost their immune systems to help prevent infections such as COVID-19, and the risk for patients who are several years removed from receiving a stem cell transplant.

Chronic Lymphocytic Leukemia

May 6th 2020, 6:11am

Article

Understanding chronic lymphocytic leukemia.

COVID-19's Impact on CLL, Myeloma Clinical Trials

May 5th 2020, 5:00pm

Article

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 & Cancer Care for Patients”, Dr. Ian Flinn and Dr. Saad Usmani how the new coronavirus has affected stem cell transplantations as well as the management of chronic lymphocytic leukemia and myeloma clinical trials.